CME 10-K Annual Reports

CME Group Inc. reported a robust fiscal year 2024, demonstrating strong performance with total revenues increasing by 10% to $6.13 billion and net income rising by 9% to $3.53 billion. This growth was primarily driven by a 10% increase in contract volume across its diverse asset classes, including significant gains in interest rates, energy, and metals. The company's strategic initiatives, particularly its expansion in global markets and continued investment in technology, including its partnership with Google Cloud for infrastructure modernization, appear to be yielding positive results. Despite a competitive and evolving regulatory landscape, CME Group maintained its leading position by offering a broad product slate and efficient clearing services. The company's operational resilience is highlighted by its continued emphasis on technology upgrades and cybersecurity measures. Furthermore, CME Group demonstrated a commitment to returning capital to shareholders through dividends and an authorized share repurchase program. While the company faces ongoing market and regulatory risks, its diversified revenue streams and strategic focus on innovation and customer efficiency position it favorably for continued growth and stability in the financial markets.

CME Group Inc. reported a strong financial performance for the year ended December 31, 2023, with total revenues increasing by 11% to $5.58 billion and net income rising by 20% to $3.23 billion. This growth was primarily driven by a 12% increase in clearing and transaction fees, supported by a 4% rise in total contract volume and an 8% increase in the average rate per contract. The company saw significant strength in its interest rate products, with a 16% increase in average daily volume, benefiting from higher market volatility due to fluctuating yields and Federal Reserve policy uncertainty. Strategic initiatives focused on global growth, business diversification, and operational excellence appear to be yielding positive results. The company continues to innovate with new product launches across asset classes and expand its global customer base, with a notable 13% growth in trading volume during European hours and 11% during Latin American hours. The partnership with Google Cloud is progressing, with the migration of non-latency sensitive applications to the cloud, aiming to enhance data capabilities and commercialize new products. CME Group remains committed to returning capital to shareholders through dividends and share repurchases, underscoring its financial stability and forward-looking strategy.

CME Group Inc. reported strong performance for the fiscal year ended December 31, 2022, with total revenues reaching $5.02 billion, a 7% increase year-over-year. This growth was primarily driven by a 10% rise in clearing and transaction fees, which benefited from an 18% increase in total contract volume. Key drivers for the volume increase included higher volatility in interest rate and equity index markets, influenced by inflation and Federal Reserve monetary policy. The company also saw a 6% increase in market data and information services revenue. Despite higher licensing and fee agreements expenses, total operating expenses decreased by 2% due to lower compensation and benefits costs, and professional fees. This led to an improved operating margin of 60.1%. Net income attributable to CME Group rose by 2% to $2.69 billion, resulting in diluted earnings per share of $7.40. The company also demonstrated robust cash flow from operations, increasing by 27% to $3.06 billion, supporting strategic investments and shareholder returns.

CME Group Inc.'s 2021 10-K report indicates a year of resilience and strategic positioning, despite a 4% decrease in total revenue to $4.69 billion compared to 2020's $4.88 billion. This revenue dip was primarily driven by a 3% decline in clearing and transaction fees, which form the bulk of the company's income, influenced by lower trading volumes in certain asset classes like energy and metals due to reduced market volatility post-2020 highs. However, the company demonstrated strong expense management, with total expenses decreasing by 9%, leading to an improved operating margin of 56% and a significant 25% increase in net income attributable to CME Group to $2.64 billion. Strategically, CME Group continued its focus on expanding its global reach and diversifying its offerings. Key initiatives included the ongoing migration of the EBS platform to CME Globex, the formation of the OSTTRA joint venture for post-trade services, and a significant 10-year partnership with Google Cloud to accelerate cloud adoption and enhance data capabilities. The company also saw growth in its market data services and made strides in its transition to alternative reference rates like SOFR. With a solid cash flow from operations and a healthy balance sheet, CME Group appears well-positioned to navigate market dynamics, invest in innovation, and continue returning capital to shareholders.

CME Group Inc. reported relatively stable revenues in 2020, with total revenues at $4.88 billion, largely in line with the previous year. The company experienced a slight decrease in clearing and transaction fees, primarily driven by lower volumes in interest rate and agricultural commodity products, although this was offset by growth in equity index and energy products. Market data and information services revenue saw a healthy increase of 5%. Despite increased licensing and professional fees, overall operating expenses decreased slightly due to reductions in compensation, travel, and marketing, partly influenced by the COVID-19 pandemic and remote work trends. The company maintained a strong financial position, with significant liquidity and a stable debt profile. CME Group continued its strategic initiatives to diversify its business and enhance customer efficiencies. A notable development was the agreement to combine post-trade services into a 50/50 joint venture with IHS Markit, expected to close in mid-2021. The report highlights the company's resilience and adaptability, navigating market volatility and adapting to operational changes like the closure of its open outcry trading floor, with electronic trading continuing to dominate. For investors, CME Group demonstrated consistent performance and a commitment to returning capital through dividends. The company's diversified product offerings across various asset classes, coupled with its central counterparty clearing services, position it as a critical piece of global financial market infrastructure. The report also addresses the ongoing impact of global economic conditions and regulatory environments as key factors influencing future performance.

CME Group Inc.'s 2019 10-K filing highlights a stable year for contract volume, with an overall average daily volume of 19.2 million contracts, largely driven by interest rate and metals products. The company successfully integrated the NEX acquisition, which expanded its product offerings and global reach, particularly in cash and OTC markets. Strategic initiatives focused on global growth, business diversification, and customer efficiency, with notable product launches and expansions in key asset classes. The company's financial performance remained strong, reflecting its diversified revenue streams and robust operational capabilities. Despite facing a competitive landscape and evolving regulatory environment, CME Group demonstrated resilience and continued its strategic expansion. Investors should note the company's commitment to returning capital through dividends, balanced with strategic investments for future growth. The ongoing focus on technological innovation and customer service positions CME Group to navigate market dynamics effectively.

CME Group Inc. reported strong performance in its 2018 fiscal year, characterized by robust revenue growth and an increase in average daily trading volumes across key asset classes. The acquisition of NEX Group plc in November 2018 was a significant event, expanding CME's reach into cash and OTC markets and diversifying its product and service offerings, particularly in fixed income and foreign exchange. Financially, the company demonstrated resilience, with total revenues growing to $4.31 billion. Despite increased operating expenses related to the NEX integration and other strategic initiatives, CME Group maintained healthy operating margins. The company's strategic focus on maximizing futures and options growth, diversifying its business, and delivering capital efficiency appears to be driving positive results. Investors will likely find the company's continued investment in technology and global expansion reassuring, though the competitive and regulatory landscapes remain key areas to monitor.

CME Group Inc. reported solid financial performance in 2017, driven by an increase in average daily contract volume and revenue growth across most product lines. The company experienced a notable surge in interest rate, energy, and metal contracts, reflecting market volatility and evolving economic conditions. Electronic trading continues to dominate, accounting for 89% of total volume, highlighting the company's investment in technology. Financially, CME Group demonstrated strong operational leverage with increased operating income and net income compared to the previous year. The company also returned significant capital to shareholders through dividends, reinforcing its commitment to shareholder value. Despite facing a competitive landscape and evolving regulatory environment, CME Group maintained its leading market position, supported by its diverse product offerings, robust clearing services, and technological capabilities.

CME Group Inc. reported solid financial performance for the fiscal year ending December 30, 2016. The company experienced robust growth in total revenues, driven primarily by a significant increase in clearing and transaction fees, which rose by 9% year-over-year. This growth was fueled by a 12% increase in total contract volume, particularly in interest rate, energy, and metal products, reflecting heightened market volatility due to economic and political uncertainties. The company's strategic initiatives, including product innovation and global expansion, continue to yield positive results. CME Group maintained a strong operational efficiency, with operating income increasing by 11% and a healthy operating margin of 61%. The company also returned significant value to shareholders through dividends, with a notable increase in the quarterly dividend and a substantial annual variable dividend. Looking ahead, CME Group is well-positioned to navigate the evolving regulatory landscape and capitalize on opportunities arising from market dynamics.

CME Group Inc. reported revenues of $3.327 billion for the year ended December 30, 2015, a 7% increase from the prior year, primarily driven by growth in clearing and transaction fees and market data services. The company demonstrated robust operating income of $1.989 billion, indicating strong operational efficiency. Net income attributable to CME Group was $1.247 billion, resulting in diluted earnings per share of $3.69. The company's strategy continues to focus on leading core business innovation, expanding product offerings, globalizing its operations, growing its customer base, and strengthening its risk management and post-trade solutions. Despite the overall positive financial performance, the company faces ongoing competition and a dynamic regulatory environment, which are key factors influencing its future outlook.

CME Group Inc. reported solid performance for the fiscal year ending December 31, 2014, with total revenues reaching $3.11 billion, a 6% increase year-over-year, driven primarily by a 6% rise in clearing and transaction fees. This growth was fueled by a 9% increase in average daily contract volume across all product lines, with notable strength in interest rate and equity products. The company continues to leverage its electronic trading platform, with 80% of contract volume executed electronically. CME Group also expanded its global reach and services, including regulatory reporting solutions and its European presence through CME Clearing Europe and CME Europe Limited. The company's strategic initiatives focused on core business innovation, globalization, and enhancing its offerings in cleared swaps markets. Despite facing a competitive and evolving regulatory landscape, CME Group demonstrated resilience. The company maintained a strong liquidity position and continued to return value to shareholders through dividends. Key operational highlights include continued investment in technology and robust risk management standards, underscoring its commitment to market integrity and customer service.

CME Group Inc.'s 2013 10-K report details a solid operational year marked by a revenue increase driven primarily by higher contract volumes across its various products, including interest rates, equities, foreign exchange, agriculture, energy, and metals. The company's strategic initiatives, focused on global expansion, product innovation, and enhancing its over-the-counter (OTC) and electronic trading capabilities, appear to be yielding positive results. Despite facing a competitive and evolving regulatory landscape, particularly with the ongoing implementation of the Dodd-Frank Act, CME Group demonstrated resilience. The company's strong financial position is supported by consistent clearing and transaction fee revenues and prudent expense management, allowing for continued investment in technology and services that maintain its market leadership. Key financial highlights include a modest increase in total revenues compared to the previous year, driven by a 9% rise in total contract volume. While the average rate per contract saw a slight decrease due to a shift in product mix towards lower-fee interest rate products, the overall revenue growth indicates a healthy operational performance. CME Group also continued its commitment to shareholder returns through consistent dividend payments and strategic capital allocation. The company's diversified product offering and robust electronic trading platform remain key competitive strengths, positioning it to navigate market volatility and regulatory changes effectively.

CME Group Inc. (CME) reported its 2012 fiscal year results, showcasing a resilient business despite a challenging economic environment marked by uncertainty in the U.S. and Europe. The company demonstrated its ability to adapt and grow through strategic acquisitions, such as the integration of KCBT, and the formation of new joint ventures like S&P/Dow Jones Indices LLC, which diversifies its revenue streams into index services. CME's core business remains strong, driven by its diverse product lines across major asset classes and its leading electronic trading platform, CME Globex. The company navigated a complex regulatory landscape, including the ongoing implementation of the Dodd-Frank Act, which it views as an opportunity for growth, particularly in over-the-counter (OTC) clearing services. CME's strategic focus on globalization, expanding its customer base internationally, and enhancing its technology infrastructure positions it for continued success. While facing competition and potential regulatory shifts, CME's integrated approach to trading, clearing, and market data services, coupled with a commitment to innovation and risk management, underpins its market leadership.

CME Group Inc.'s 2011 Form 10-K details a year of robust growth and strategic expansion, marked by a significant increase in total revenues to $3.28 billion, up 9% from 2010. This growth was primarily driven by a 9% rise in clearing and transaction fees, reflecting a 10% increase in overall contract volume, largely from electronic trading platforms. The company also saw an 8% increase in market data and information services revenue, bolstered by its joint venture in index services. Strategically, CME Group continued its global expansion, launching CME Clearing Europe and focusing on emerging markets. The company also invested in technology and services, including a new co-location business, to enhance its offerings. Despite ongoing regulatory scrutiny and the significant impact of the MF Global bankruptcy, which necessitated financial guarantees and incurred related expenses, CME Group demonstrated resilience, maintaining strong operational performance and a commitment to shareholder returns through dividends and share repurchases. The report highlights a solid financial position and a clear strategy for future growth across asset classes and geographies.

CME Group Inc. (CME) reported robust financial performance for the fiscal year ending December 31, 2010. The company experienced a significant increase in total revenues, driven primarily by a rise in clearing and transaction fees, bolstered by higher trading volumes across key product lines like interest rate and energy futures. This growth was also supported by an expansion in market data and information services, partly due to strategic initiatives like the joint venture with Dow Jones. Strategically, CME Group continued its expansion by acquiring Elysian Systems Ltd. and establishing CME Clearing Europe, aiming to broaden its global reach and diversify its service offerings, particularly in the over-the-counter (OTC) derivatives market. The company's integrated business model, which combines trading execution, clearing, and settlement services, remained a core strength. Despite facing a dynamic and competitive regulatory environment, notably the ongoing implementation of the Dodd-Frank Act, CME Group demonstrated resilience and strategic foresight in navigating these changes. For investors, the report highlights steady revenue growth, a diversified product portfolio, and strategic investments in technology and global expansion. The company maintained its commitment to shareholder returns through consistent dividend payments and share repurchases. While acknowledging the inherent risks in the financial industry and the evolving regulatory landscape, CME Group's financial results and strategic initiatives position it favorably for continued operations and growth.

CME Group Inc. (CME) reported solid financial performance for the year ended December 31, 2009, navigating a challenging economic environment. Total revenues reached $2.61 billion, a slight increase from the prior year, driven by strong performance in quotation data fees and stable clearing and transaction fees, despite a notable decline in trading volume, particularly in interest rate products. The company successfully integrated the NYMEX acquisition, contributing to its diverse product portfolio. CME Group demonstrated resilience by maintaining its market leadership and investing in technology, including enhancements to its Globex platform and expansion into over-the-counter markets with services like CME ClearPort. Despite the economic headwinds, the company maintained a strong balance sheet and generated substantial operating cash flow. The focus on growing its core business, globalizing its operations, and serving the over-the-counter markets remains central to its strategy. While the company faced challenges such as increased regulatory scrutiny and market volatility, its robust financial safeguards and clearing operations protected customers from counterparty failures. CME Group ended the year with a healthy liquidity position and continued its commitment to shareholder returns through a consistent quarterly dividend.

CME Group Inc.'s 2008 10-K report details a year marked by significant strategic expansion through the acquisition of NYMEX Holdings, which broadened its product offerings into energy and metals. Despite facing a challenging macroeconomic environment characterized by credit market volatility and economic recession, CME Group demonstrated resilience, with total revenues growing by 46% to $2.56 billion, primarily driven by a 48% increase in clearing and transaction fees. The company's robust electronic trading platform, CME Globex, processed a significant majority of its trading volume. Key financial highlights include a strong operating income of $1.58 billion and net income of $715.5 million. However, the company also incurred a substantial non-cash impairment charge of $274.5 million on its investment in BM&F Bovespa due to market declines. CME Group emphasized its commitment to technological advancement, global reach, and serving over-the-counter markets as core growth strategies.

CME Group Inc. (CME) reported strong performance for the fiscal year ended December 31, 2007, primarily driven by its merger with CBOT Holdings Inc. This strategic combination significantly expanded CME's product offerings and market reach across various asset classes, including interest rates, equities, foreign exchange, and commodities. The company highlighted substantial revenue growth, fueled by increased trading volumes and a higher percentage of electronic trading, as well as strategic initiatives like penetrating over-the-counter markets and globalizing its business. Financially, the company demonstrated robust revenue growth, with clearing and transaction fees as the primary driver. This growth was complemented by strong performance in quotation data fees and processing services. While operating expenses also increased, largely due to merger-related integration costs, compensation, and technology investments, CME Group maintained a healthy operating margin. The company's strategic focus on leveraging its technology and expanding its product suite positions it well for continued growth and operational efficiencies in the evolving financial markets.

CME Group Inc. (CME) reported robust performance for the fiscal year ending December 31, 2006. The company experienced significant growth in trading volume, exceeding one billion contracts for the second consecutive year, reaching a record 1.3 billion contracts, a 28% increase over 2005. This growth was driven by strong performances across all major product lines, particularly interest rates, equities, and foreign exchange, fueled by technological enhancements, evolving market conditions, and strategic initiatives. Financially, CME saw total revenues increase by 22% to $1.09 billion, primarily from clearing and transaction fees, which rose 24%. The company also reported an operating income of $620.9 million, with an operating margin of 57%. Key strategic developments during the year included the acquisition of Swapstream, an electronic trading platform for interest rate swaps, and the announcement of a merger with CBOT Holdings, Inc., aiming to create operational and cost efficiencies. The company also expanded its electronic trading services for NYMEX products. Looking ahead, CME is focused on continued organic growth, expanding its product offerings, providing third-party services, and leveraging its technology. The company's strong financial results and strategic expansion plans position it for continued growth in the global derivatives market.

Chicago Mercantile Exchange Holdings Inc. (CME) reported a record year in 2005, with trading volume surpassing one billion contracts for the first time. The company's strong performance was driven by significant growth in electronic trading, which accounted for 70% of total volume, and robust activity in its key interest rate and equity products, particularly CME Eurodollar and S&P 500/NASDAQ-100 index futures. CME's integrated business model, featuring a wholly-owned clearing house and a scalable technology platform, underpins its competitive strengths and ability to handle increasing volumes. The company highlights its commitment to innovation and expansion through strategies including broadening customer access, introducing new products, providing processing services to third parties, and pursuing strategic alliances. Despite facing increasing competition, CME's focus on liquidity, benchmark products, and technological advancement positions it for continued growth. Investors should note the company's reliance on its core products and the ongoing technological development required to maintain its market leadership.

Chicago Mercantile Exchange Inc. (CME) reported strong performance for the fiscal year ended December 31, 2004, demonstrating robust growth and expanding its market leadership in the derivatives sector. The company achieved record trading volume, a significant increase over the previous year, driven by its strong product portfolio, particularly in interest rate and equity index futures. CME's strategic focus on expanding electronic trading capabilities and its wholly-owned, large-scale clearing house proved to be key competitive advantages. Looking ahead, CME outlined a growth strategy centered on expanding its core business, introducing new products, providing transaction processing services to third parties, and pursuing strategic alliances and acquisitions. The company highlighted its commitment to technological innovation and global reach as critical to maintaining its competitive edge in an evolving financial landscape. Investors can view CME's performance as a testament to its ability to adapt to market dynamics and capitalize on opportunities within the global risk management ecosystem.

Chicago Mercantile Exchange Holdings Inc. (CME) reported strong performance for the fiscal year ended December 31, 2003, solidifying its position as the largest futures exchange in the United States by trading volume. The company achieved record trading volume, a significant increase from the previous year, driven by growth across its key product lines, particularly interest rate and equity derivatives. CME's strategy of innovation and expansion, including the development of electronic trading capabilities and new product offerings like TRAKRS, has been a key driver of this success. The company's wholly-owned clearing house continues to be a significant competitive advantage, ensuring stability and efficiency for its members. CME also highlighted its global reach and ongoing investments in technology to enhance its trading platforms and accommodate increasing volumes. The company's transition to a for-profit entity in 2000 appears to be yielding positive results, with a focus on optimizing volume, efficiency, and liquidity, positioning CME for continued growth in the dynamic derivatives market.

CME Group Inc. (CME) reported a strong performance for the fiscal year ended December 31, 2002, marked by record trading volume and a significant increase in revenue. The company successfully completed its initial public offering (IPO) in December 2002, listing on the New York Stock Exchange, and adopted a for-profit structure. This marks a significant transition from its historical not-for-profit status, aiming to optimize volume, efficiency, and liquidity. The company's core business involves bringing together buyers and sellers of derivatives products through open outcry, its GLOBEX electronic trading platform, and cleared privately negotiated transactions. CME offers a diverse portfolio of products, including interest rate, equity index, foreign exchange, and commodity futures and options. Its key products, such as Eurodollar and S&P 500 Index contracts, are considered global financial benchmarks. The wholly owned clearing house provides a significant competitive advantage by guaranteeing, clearing, and settling all contracts traded on the exchange.

Chicago Mercantile Exchange Holdings Inc. (CME) reported strong financial performance for the fiscal year ended December 31, 2001. The company achieved record trading volume and significant revenue growth, marking a substantial turnaround from a net loss in the prior year. This performance is attributed to strong activity across its key product sectors, particularly interest rate and equity products, and the successful transition to a for-profit, shareholder-owned corporation. The company's strategic focus on expanding customer access, introducing new products, and leveraging its technology and clearing house capabilities positions it for continued growth in the evolving derivatives market. Investors can take note of CME's robust competitive strengths, including highly liquid markets, global benchmark products like Eurodollar and S&P 500 futures, a diverse product portfolio, and a wholly-owned, scalable clearing house. The company's commitment to technological advancement and global reach further solidifies its market leadership. The filing also details the company's growth strategies, which include expanding its core business, developing new products, and pursuing strategic alliances and acquisitions, indicating a proactive approach to capturing market opportunities.

This filing is an amendment to CME Group Inc.'s (CME) 2001 Annual Report on Form 10-K, specifically providing the Report of Independent Public Accountants for the financial statement schedules. The amendment clarifies that the original 10-K was filed on March 28, 2002, and this amendment, filed on June 9, 2002, adds details related to financial statement schedules and exhibits. For investors, the key takeaway is the confirmation of the company's financial reporting compliance and the completeness of its disclosures for the fiscal year ended December 31, 2001, following a reorganization into a holding company structure. The filing confirms that Arthur Andersen LLP audited the consolidated financial statements and found that the financial statement schedules (Schedule I - Condensed Financial Information of Registrant and Schedule II - Valuation and Qualifying Accounts) fairly state the required financial data in relation to the basic financial statements. The registrant, Chicago Mercantile Exchange Holdings Inc., had a single asset, its investment in its wholly owned subsidiary, Chicago Mercantile Exchange Inc. (CME), valued at $250,369,000 at year-end 2001, with net income from this investment of $68,302,000. The subsidiary, CME, maintained a $500.0 million credit facility, requiring a minimum tangible net worth of $90.0 million.

Chicago Mercantile Exchange Holdings Inc. (CME) reported significant growth and a strong financial turnaround in its 2001 10-K filing. Following its demutualization in November 2000, the company transitioned to a for-profit, shareholder-owned structure. This period saw record trading volumes, with over 411.7 million contracts traded in 2001, a substantial 78.1% increase from the previous year, making CME the largest futures exchange in the U.S. by this metric. Financially, CME moved from a net loss in 2000 to a net income of $68.3 million in 2001, with revenues increasing by 70.9% to $387.2 million. The company highlights its competitive strengths, including highly liquid markets, global benchmark products like Eurodollar and S&P 500 futures, a diverse product portfolio, a wholly-owned clearing house, robust technology, and expanding global reach. CME's growth strategy focuses on expanding its core business through enhanced customer access and electronic trading, developing new products (such as E-mini contracts and exploring single stock futures), providing transaction processing services to third parties, and pursuing strategic alliances and acquisitions. The company's strong technological infrastructure and its wholly-owned clearing house provide significant operational advantages and revenue opportunities.